Can Fite Financials

CANF Stock   2.90  0.10  3.57%   
We suggest to use analysis of Can Fite Biopharma fundamentals to see if markets are presently mispricing the company. We were able to interpolate twenty-five available fundamental indicators for Can Fite Biopharma, which can be compared to its rivals. To ensure the equity is not overpriced, please confirm all Can Fite Biopharma financials, including its revenue, ebitda, and the relationship between the price to sales and gross profit . The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Can Fite to be traded at 3.48 in 90 days.
With this module, you can analyze Can financials for your investing period. You should be able to track the changes in Can Fite individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Can Fite Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Can Fite's financial statements are interrelated, with each one affecting the others. For example, an increase in Can Fite's assets may result in an increase in income on the income statement.
Evaluating Can Fite's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of Can Fite's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the Can Fite's relative financial performance

Chance Of Distress

Over 67

 
100  
 
Zero
Quite High
Can Fite Biopharma has more than 67 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Can Fite stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, Can Fite's odds of distress score SHOULD NOT be confused with the real chance of Can Fite Biopharma filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as Can is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include Can Fite's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in Can Fite's official financial statements usually reflect Can Fite's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Can Fite Biopharma. For example, before you start analyzing numbers published by Can accountants, it's critical to develop an understanding of what Can Fite's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Can Fite's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Can Fite's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Can Fite's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Can Fite Biopharma. Please utilize our Beneish M Score to check the likelihood of Can Fite's management manipulating its earnings.

Can Fite Company Summary

Can Fite competes with Delek, Azrieli, Bezeq Israeli, B Communications, and Alony Hetz. Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, and sexual dysfunction. Can-Fite BioPharma Ltd. was founded in 1994 and is headquartered in Petah-Tikva, Israel. CAN FITE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 7 people.
Foreign Associate
  USA
InstrumentIsrael Stock View All
ExchangeTel Aviv Stock Exchange
CIK Number0001536196
ISINIL0010944739
RegionMiddle East
Business Address10 Bareket Street,
SectorBiotechnology
IndustryHealth Care
BenchmarkNYSE Composite
Websitewww.canfite.com
Phone(972) 3 9249378
You should never invest in Can Fite without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Can Stock, because this is throwing your money away. Analyzing the key information contained in Can Fite's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Can Fite Key Financial Ratios

Generally speaking, Can Fite's financial ratios allow both analysts and investors to convert raw data from Can Fite's financial statements into concise, actionable information that can be used to evaluate the performance of Can Fite over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Can Fite Biopharma reports annually and quarterly.

Can Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Can Fite's current stock value. Our valuation model uses many indicators to compare Can Fite value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Can Fite competition to find correlations between indicators driving Can Fite's intrinsic value. More Info.
Can Fite Biopharma is number one stock in beta category among related companies. It is number one stock in cash flow from operations category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Can Fite by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Can Fite's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Can Fite's earnings, one of the primary drivers of an investment's value.

Can Fite Biopharma Systematic Risk

Can Fite's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Can Fite volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Can Fite Biopharma correlated with the market. If Beta is less than 0 Can Fite generally moves in the opposite direction as compared to the market. If Can Fite Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Can Fite Biopharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Can Fite is generally in the same direction as the market. If Beta > 1 Can Fite moves generally in the same direction as, but more than the movement of the benchmark.

About Can Fite Financials

What exactly are Can Fite Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Can Fite's income statement, its balance sheet, and the statement of cash flows. Potential Can Fite investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Can Fite investors may use each financial statement separately, they are all related. The changes in Can Fite's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Can Fite's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Can Fite Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Can Fite is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Can has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Can Fite's financials are consistent with your investment objective using the following steps:
  • Review Can Fite's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Can Fite's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Can Fite's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Can Fite's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Can Fite March 28, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Can Fite help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Can Fite Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Can Fite Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing Can Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Can Fite's daily price indicators and compare them against related drivers.
When determining whether Can Fite Biopharma is a strong investment it is important to analyze Can Fite's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Can Fite's future performance. For an informed investment choice regarding Can Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Can Fite Biopharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Can Stock analysis

When running Can Fite's price analysis, check to measure Can Fite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Can Fite is operating at the current time. Most of Can Fite's value examination focuses on studying past and present price action to predict the probability of Can Fite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Can Fite's price. Additionally, you may evaluate how the addition of Can Fite to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Please note, there is a significant difference between Can Fite's value and its price as these two are different measures arrived at by different means. Investors typically determine if Can Fite is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Can Fite's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.